These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Conjugation of a Ru(II) arene complex to neomycin or to guanidinoneomycin leads to compounds with differential cytotoxicities and accumulation between cancer and normal cells. Grau-Campistany A; Massaguer A; Carrion-Salip D; Barragán F; Artigas G; López-Senín P; Moreno V; Marchán V Mol Pharm; 2013 May; 10(5):1964-76. PubMed ID: 23510087 [TBL] [Abstract][Full Text] [Related]
9. Identification of the structural determinants for anticancer activity of a ruthenium arene peptide conjugate. Meier SM; Novak M; Kandioller W; Jakupec MA; Arion VB; Metzler-Nolte N; Keppler BK; Hartinger CG Chemistry; 2013 Jul; 19(28):9297-307. PubMed ID: 23712572 [TBL] [Abstract][Full Text] [Related]
10. Design of Ru-arene Complexes for Antitumor Drugs. Su W; Li Y; Li P Mini Rev Med Chem; 2018; 18(2):184-193. PubMed ID: 28494728 [TBL] [Abstract][Full Text] [Related]
12. Discovery of high in vitro and in vivo antitumor activities of organometallic ruthenium(ii)-arene complexes with 5,7-dihalogenated-2-methyl-8-quinolinol. Meng T; Qin QP; Chen ZL; Zou HH; Wang K; Liang FP Dalton Trans; 2019 Apr; 48(16):5352-5360. PubMed ID: 30942794 [TBL] [Abstract][Full Text] [Related]
13. Ruthenium(ii) arene NSAID complexes: inhibition of cyclooxygenase and antiproliferative activity against cancer cell lines. Mandal P; Kundu BK; Vyas K; Sabu V; Helen A; Dhankhar SS; Nagaraja CM; Bhattacherjee D; Bhabak KP; Mukhopadhyay S Dalton Trans; 2018 Jan; 47(2):517-527. PubMed ID: 29235601 [TBL] [Abstract][Full Text] [Related]
14. Metal complexes of curcumin for cellular imaging, targeting, and photoinduced anticancer activity. Banerjee S; Chakravarty AR Acc Chem Res; 2015 Jul; 48(7):2075-83. PubMed ID: 26158541 [TBL] [Abstract][Full Text] [Related]
15. Arene-Ru(II) complexes of curcumin exert antitumor activity via proteasome inhibition and apoptosis induction. Bonfili L; Pettinari R; Cuccioloni M; Cecarini V; Mozzicafreddo M; Angeletti M; Lupidi G; Marchetti F; Pettinari C; Eleuteri AM ChemMedChem; 2012 Nov; 7(11):2010-20. PubMed ID: 22997162 [TBL] [Abstract][Full Text] [Related]
16. Dimetallic Ru(II) arene complexes appended on bis-salicylaldimine induce cancer cell death and suppress invasion via p53-dependent signaling. Rahman FU; Bhatti MZ; Ali A; Duong HQ; Zhang Y; Ji X; Lin Y; Wang H; Li ZT; Zhang DW Eur J Med Chem; 2018 Sep; 157():1480-1490. PubMed ID: 30282320 [TBL] [Abstract][Full Text] [Related]
17. 3-Hydroxyflavones vs. 3-hydroxyquinolinones: structure-activity relationships and stability studies on Ru(II)(arene) anticancer complexes with biologically active ligands. Kurzwernhart A; Kandioller W; Enyedy ÉA; Novak M; Jakupec MA; Keppler BK; Hartinger CG Dalton Trans; 2013 May; 42(17):6193-202. PubMed ID: 23168616 [TBL] [Abstract][Full Text] [Related]
18. Phenylazo-pyridine and phenylazo-pyrazole chlorido ruthenium(II) arene complexes: arene loss, aquation, and cancer cell cytotoxicity. Dougan SJ; Melchart M; Habtemariam A; Parsons S; Sadler PJ Inorg Chem; 2006 Dec; 45(26):10882-94. PubMed ID: 17173447 [TBL] [Abstract][Full Text] [Related]
19. Analysis of ruthenium anticancer agents by MEEKC-UV and MEEKC-ICP-MS: Impact of structural motifs on lipophilicity and biological activity. Giringer K; Holtkamp HU; Movassaghi S; Tremlett WDJ; Lam NYS; Kubanik M; Hartinger CG Electrophoresis; 2018 May; 39(9-10):1201-1207. PubMed ID: 29400408 [TBL] [Abstract][Full Text] [Related]
20. Synthesis, Structure, and Anticancer Activity of Arene-Ruthenium(II) Complexes with Acylpyrazolones Bearing Aliphatic Groups in the Acyl Moiety. Palmucci J; Marchetti F; Pettinari R; Pettinari C; Scopelliti R; Riedel T; Therrien B; Galindo A; Dyson PJ Inorg Chem; 2016 Nov; 55(22):11770-11781. PubMed ID: 27934319 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]